CNTN – (US:NASDAQ)

News

Hillstream Biopharma (CNTN) was downgraded by Wall Street Zen from "h
Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results
Hillstream Biopharma (CNTN) is now covered by Weiss Ratings. They set a "sell (e+)" rating on the stock.
Canton Strategic Holdings, Inc. Chairman and CEO Mark Wendland Elected to Canton Foundation Board
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com